TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/20/23 18:27 | 12/20/23 | BCAB | Bioatla, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Short Jay M Phd | CA | DOT | CEO | P | 107 | 2.14 | 0 | 50 | 2 | 3,053 | D | ||||||||||||||
3/30/23 19:17 | 3/29/23 | BCAB | Bioatla, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Short Jay M Phd | CA | DOT | CEO | P | 101 | 2.47 | 0 | 41 | 1 | 3,026 | D | ||||||||||||||
8/15/22 16:37 | 8/12/22 | BCAB | Bioatla, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Short Jay M Phd | CA | DOT | CEO | P | 207 | 7.84 | 0 | 26 | 1 | 3,010 | D | ||||||||||||||
6/23/22 16:59 | 6/21/22 | BCAB | Bioatla, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Short Jay M Phd | CA | DOT | CEO | P.m | 198 | 2.86 | 0 | 69 | 2 | 2,989 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |